(Sioux Falls, SD) – More than 65 percent of people with diabetes die from heart disease or stroke, according to the American Diabetes Association (ADA). Sanford Research/USD announced today it has received an ADA Career Development Award to help understand why this occurs, which could ultimately save lives. The $878,686 grant over five years will be used to explore the connection between diabetes and susceptibility to heart disease in patients with both type 1 and type 2 diabetes. Qiangrong Liang, MD/PhD and a team of researchers at Sanford Research/USD Cardiovascular Research Center will use the grant to expand the research capacity by recruiting staff and purchasing equipment and supplies.
"It is a great honor to be chosen as the recipient of this highly competitive grant," Dr. Liang said. "It is my hope that the research discoveries from this project will help the ADA in its mission to find a cure and improve the lives of people with diabetes."
The ADA Career Development Awards are designed to assist outstanding assistant professor level faculty investigators in conducting diabetes-related research. Sanford Research/USD is one of the very few institutions awarded this grant for 2009.
"It is a credit to Dr. Liang’s research team they were chosen for this very competitive award," added Ben Perryman, PhD, Sanford Health Vice President of Research. "His team has already made significant discoveries, and this grant shows national recognition of the important work they are doing to understand the cardiovascular complications of diabetes."
About Sanford Research/USD
Sanford Research/USD has made significant contributions to the research areas of cardiovascular health, women’s health, cancer biology, disparities, pediatrics, metabolism/nutrition and genomics. Cardiovascular Research Center (CRC) is the most completely developed component of Sanford Research/USD with what is considered to be the nation’s largest single team of research scientists studying cell remodeling and heart failure. Key research areas include diabetes, cardiac disease mutations, thyroid disorders, neuro-hormonal abnormalities and vascular growth regulation. With seven principal investigators led by Martin Gerdes, PhD, and a staff of over 40, the CRC is attracting significant NIH and other related funding.
Stacy Bauer Jones | Media Relations Coordinator
(605) 328-7056 | email@example.com